DocMorris AG (OTCMKTS:ZRSEF – Get Free Report) was the target of a significant decrease in short interest during the month of June. As of June 15th, there was short interest totaling 156,154 shares, a decrease of 45.9% from the May 31st total of 288,775 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ? days.
DocMorris Stock Performance
ZRSEF opened at $7.45 on Wednesday. The firm has a 50-day moving average price of $7.45 and a 200-day moving average price of $7.67. DocMorris has a twelve month low of $7.45 and a twelve month high of $42.50.
About DocMorris
DocMorris is a leading European online pharmacy brand and a subsidiary of the Swiss-based Zur Rose Group (OTCMKTS:ZRSEF). Through its digital platform, the company offers mail-order dispensing of prescription medications and over-the-counter health products directly to consumers’ homes.
The company’s core services include the online sale and delivery of prescription and non-prescription drugs, health supplements, personal care items and medical devices. Leveraging its e-commerce infrastructure and proprietary pharmacy management systems, DocMorris also provides digital health solutions such as telemedicine consultations, medication management tools and mobile app-based healthcare services.
Originally launched in the early 2000s in Germany, DocMorris has expanded its reach to serve customers in multiple European countries, including the Netherlands, Belgium, Luxembourg and Switzerland.
Recommended Stories
- Five stocks we like better than DocMorris
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Receive News & Ratings for DocMorris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocMorris and related companies with MarketBeat.com's FREE daily email newsletter.
